Avantor, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Avantor, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-12-31 was $1.50M, a 62.50% decline year-over-year.
- Avantor, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $15.70M, a 70.65% increase year-over-year.
- Avantor, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $4.50M.
- Avantor, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $38.90M.
- Avantor, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $60.60M, a 1217.39% increase from fiscal 2023.
- Avantor, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $4.60M, a 12.20% increase from fiscal 2022.
- Avantor, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $4.10M, a 93.68% decline from fiscal 2021.
- Avantor, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $64.90M, a 445.38% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $60.60M 10-K · filed 2025-02-07 |
| 2024-09-30 | $15.70M 10-Q · filed 2024-10-25 | $63.10M derived: sum of 4 quarters · filed 2025-02-07 |
| 2024-06-30 | $4.50M 10-Q · filed 2024-07-26 | $56.60M derived: sum of 4 quarters · filed 2025-02-07 |
| 2024-03-31 | $38.90M 10-Q · filed 2024-04-26 | $49.00M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $4.60M 10-K · filed 2025-02-07 |
| 2023-09-30 | $9.20M 10-Q · filed 2024-10-25 | $1.40M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | -$3.10M 10-Q · filed 2024-07-26 | -$3.10M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | -$5.50M 10-Q · filed 2024-04-26 | -$2.20M derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $4.10M 10-K · filed 2025-02-07 |
| 2022-09-30 | $4.70M 10-Q · filed 2023-10-27 | $9.30M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | -$2.20M 10-Q · filed 2023-07-28 | $43.40M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $800.00K 10-Q · filed 2023-04-28 | $54.80M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $64.90M 10-K · filed 2024-02-14 |
| 2021-09-30 | $38.80M 10-Q · filed 2022-10-28 | $57.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $9.20M 10-Q · filed 2022-07-29 | $23.30M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $10.90M 10-Q · filed 2022-04-29 | $16.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | -$1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $11.90M 10-K · filed 2023-02-14 |
| 2020-09-30 | $5.10M 10-Q · filed 2021-10-29 | |
| 2020-06-30 | $1.90M 10-Q · filed 2021-07-30 | |
| 2020-03-31 | $6.80M 10-Q · filed 2021-04-28 | |
| 2019-12-31 | $700.00K 10-K · filed 2022-02-11 | |
| 2018-12-31 | $0.00 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |